| Literature DB >> 30853790 |
Mostafa A Mostafa1, Naglaa M Kamal2, Sherif Eltaher3, Yahia Hamed1, Hany Abdelaziz1, Walid Abdelghany1, Efat Aser1, Eman Fawzy1, Laila M Sherief4.
Abstract
BACKGROUND AND OBJECTIVES: To evaluate the knowledge of the primary health care physicians (PHCP) in Kalubia governorate, Egypt, about the causes, diagnosis, complications, and treatment of neonatal hyperbilirubinemia (NHB).Entities:
Keywords: Education; medical diagnosis; newborn; newborn screening
Year: 2019 PMID: 30853790 PMCID: PMC6399760 DOI: 10.1177/1179556518824375
Source DB: PubMed Journal: Clin Med Insights Pediatr ISSN: 1179-5565
Demographic data of the participants.
| Demographic data | |
|---|---|
| Sex | |
| Male: No. (%) | 76 (18.2) |
| Female: No. (%) | 344 (81.8) |
| Age (mean ± SD, y) | 28.5 ± 5.2 |
| Work experience (mean ± SD, y) | 3.3 ± 4.4 |
| Educational level | |
| MBBCh only: No. (%) | 366 (87.4) |
| Master’s degree: No. (%) | 53 (12.6) |
| Received neonatal care training | |
| Yes: No. (%) | 60 (14.3) |
| None: No. (%) | 334 (85.7) |
Knowledge about methods of screening and assessment of the severity of neonatal hyperbilirubinemia.
| Variant | No. (%) |
|---|---|
| Cephalocaudal evaluation | 256 (61.0) |
| Total serum bilirubin assessment | 365 (87.1) |
| Transcutaneous bilirubinometry | 138 (33.0) |
| Color of urine | 117 (27.9) |
| Color of stool | 77 (18.4) |
Knowledge about causes of neonatal hyperbilirubinemia.
| Causes of neonatal hyperbilirubinemia | No. (%) |
|---|---|
| ABO incompatibility | 357 (85.2) |
| Rh incompatibility | 331 (79.0) |
| Sepsis | 201 (48.0) |
| G6PD | 203 (48.4) |
| Prematurity | 313 (74.7) |
| Physiological | 401 (95.7) |
Knowledge about alarming signs for complications of neonatal hyperbilirubinemia.
| Sign | No. (%) |
|---|---|
| Refusal of feeding | 233 (55.6) |
| Convulsions | 343 (81.6) |
| High-pitched cry | 62 (14.8) |
| Fever | 141 (33.6) |
| Arching of the back | 42 (10.0) |
| Muscle tone changes | 57 (13.6) |
Knowledge about lines of management of neonatal hyperbilirubinemia.
| Management interventions | No. (%) |
|---|---|
| Drugs (like silymarin) | 182 (43.4) |
| Drugs (like phenobarbitone) | 55 (13.1) |
| Vitamins | 201 (48.0) |
| Recommendations to the mothers | |
| Expose the baby to sunlight | 57 (13.6) |
| Expose the baby to fluorescent light | 125 (29.8) |
| Continue breast feeding | 317 (71.6) |
| Phototherapy and exchange transfusion | 379 (90.4) |
Regression analysis of factors affecting physicians’ knowledge of neonatal hyperbilirubinemia in the studied physicians.
| Beta | 95% CI for Beta | P value | ||
|---|---|---|---|---|
| Age | 0.121 | −0.067 | 4.84 | >0.05 |
| Sex | 0.091 | −0.013 | 4.025 | >0.05 |
| Duration of work | 0.223 | 1.25 | 3.58 | <0.001 |
| Level of education | 0.368 | 5.21 | 7.35 | <0.001 |
| Neo-natal care training | 0.28 | 3.21 | 5.64 | <0.001 |
Confidence Interval